Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$3.24 - $5.18 $15,714 - $25,123
-4,850 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$3.94 - $5.84 $17,336 - $25,696
4,400 Added 977.78%
4,850 $25,000
Q4 2019

Feb 03, 2020

SELL
$13.94 - $24.12 $36,244 - $62,712
-2,600 Reduced 85.25%
450 $10,000
Q2 2019

Aug 07, 2019

BUY
$16.27 - $20.51 $40,675 - $51,275
2,500 Added 454.55%
3,050 $59,000
Q4 2018

Feb 11, 2019

SELL
$12.41 - $22.98 $1,241 - $2,298
-100 Reduced 15.38%
550 $7,000
Q2 2017

Aug 10, 2017

BUY
N/A
650
650 $3,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $278M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Jacobi Capital Management LLC Portfolio

Follow Jacobi Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jacobi Capital Management LLC with notifications on news.